Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines.
Nefrologia (Engl Ed)
; 41(4): 412-416, 2021.
Article
Dans Anglais
| MEDLINE | ID: covidwho-2105644
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19) but only corticosteroids have demonstrated to be effective in moderate or severe affectation. In that situation, the development of vaccines for preventing the SARS-CoV-2 infection has focused the attention of the scientific community. At present, available messenger RNA-based technology vaccines have received the approval of local and international sanitary authorities. In this position statement, the Spanish Society of Nephrology wants to state that patients with chronic kidney disease and healthcare workers are at high-risk for contagion and complications of COVID-19 so they must have priority in the vaccine administration.
Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
Vaccins
/
COVID-19
/
Néphrologie
Type d'étude:
Étude pronostique
Les sujets:
Vaccins
Limites du sujet:
Humains
langue:
Anglais
Revue:
Nefrologia (Engl Ed)
Année:
2021
Type de document:
Article
Pays d'affiliation:
J.nefroe.2021.09.001
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS